Scarica l'app Stockscreener
0.8108
8.11%
0.0608
Dopo l'orario di chiusura:
.81
-0.0008
-0.10%
Precedente Chiudi:
$0.75
Aprire:
$0.7418
Volume 24 ore:
934.29K
Relative Volume:
0.48
Capitalizzazione di mercato:
$4.80M
Reddito:
-
Utile/perdita netta:
$-14.07M
Rapporto P/E:
-0.058
EPS:
-13.99
Flusso di cassa netto:
$-12.56M
1 W Prestazione:
-18.92%
1M Prestazione:
+7.68%
6M Prestazione:
-21.28%
1 anno Prestazione:
-78.09%
Intervallo 1D:
$0.7201
$0.84
Intervallo di 1 settimana:
$0.6616
$1.90
Portata 52W:
$0.60
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
Nome
Palisade Bio Inc
Settore
Industria
Telefono
(858) 704-4900
Indirizzo
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Confronta PALI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
0.8108 | 3.75M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc Borsa (PALI) Ultime notizie
Palisade Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Palisade Bio Inc. stock trendline breakdownDollar Strength & Short-Term Trading Alerts - Newser
Why Palisade Bio Inc. is moving todayJuly 2025 Big Picture & Weekly High Return Stock Forecasts - Newser
Is Palisade Bio Inc. stock poised for growthWeekly Market Summary & Real-Time Buy Signal Alerts - Newser
What’s the recovery path for long term holders of Palisade Bio Inc.July 2025 Review & Technical Pattern Recognition Alerts - Newser
Can you recover from losses in Palisade Bio Inc.Trade Analysis Report & Community Consensus Trade Alerts - Newser
What makes Palisade Bio Inc. stock price move sharplyFree Risk-Adjusted Picks With Exit Strategy - Newser
Heatmap analysis for Palisade Bio Inc. and competitorsTrade Performance Summary & Verified High Yield Trade Plans - Newser
Why Palisade Bio Inc. stock attracts strong analyst attentionGiant Leap Stock Alerts - newsyoung.net
Is Palisade Bio Inc. backed by strong institutional buyingMassive Return Before Earnings - kangso.co.kr
PALISADE BIO, INC. SEC 10-Q Report - TradingView
PALI’s 2025 Market Dance: Down -78.11% – Time to Invest? - investchronicle.com
How to monitor Palisade Bio Inc. with trend dashboardsReversal Signal Prediction Based on Volume - Newser
Institutional scanner results for Palisade Bio Inc.Summary of Reliable Long-Term Trade Models - Newser
Palisade Bio's PDE4 Inhibitor PALI-2108 Achieves 100% Clinical Response Rate in Ulcerative Colitis Trial - AInvest
How Palisade Bio Inc. stock performs during market volatilityAlgorithmic Prediction of Market Breakouts - Newser
Palisade Bio (PALI) to Release Earnings on Monday - Defense World
Recovery Signals Appearing in Palisade Bio Inc. ChartsPotential Breakout Stock List Published This Week - beatles.ru
Palisade Bio’s PALI-2108: A Promising New Treatment for Ulcerative Colitis - TipRanks
Palisade Bio Soars on Breakthrough Ulcerative Colitis Data: What Investors Need to Know - RagingBull
Is Palisade Bio Poised to Rise? - StocksToTrade
Palisade Bio reports positive data for UC drug PALI-2108 By Investing.com - Investing.com Australia
Palisade Bio Inc.’s Stock Climbs Amid Patent News: What’s Next? - timothysykes.com
Palisade Bio Reports 100% Clinical Response in Phase 1b - GlobeNewswire
Novel PDE4 Inhibitor Achieves 100% Response Rate in Phase 1b Ulcerative Colitis Trial | PALI Stock News - Stock Titan
When is the best time to buy Palisade Bio Inc. stockShort-Term Trade Setup with Forecast Insight - Newser
Applying Elliott Wave Theory to Palisade Bio Inc.Free Low Drawdown Real Time Trading Tips - Newser
Applying chart zones and confluence areas to Palisade Bio Inc.Free Weekly Top Gainers Forecast Watchlist - Newser
Palisade Bio Inc. Builds Base for Possible ReboundLow Risk High Return Opportunities Identified - metal.it
Is it the right time to buy Palisade Bio Inc. stockPowerful growth strategies - Jammu Links News
What analysts say about Palisade Bio Inc. stockBuild wealth steadily with proven investment techniques - Jammu Links News
How does Palisade Bio Inc. compare to its industry peersIdentify winners with top-tier analysis - Jammu Links News
Is Palisade Bio Inc. a growth stock or a value stockMaximize your returns with smart trade entries - Jammu Links News
Should I hold or sell Palisade Bio Inc. stock in 2025Skyrocketing investment returns - Jammu Links News
What are Palisade Bio Inc. company’s key revenue driversMarket-crushing stock picks - Jammu Links News
What institutional investors are buying Palisade Bio Inc. stockExceptional portfolio growth - Jammu Links News
How does Palisade Bio Inc. generate profit in a changing economyGet daily updates on promising stocks - Jammu Links News
When is Palisade Bio Inc. stock expected to show significant growthInvest confidently with expert support - Jammu Links News
What catalysts could drive Palisade Bio Inc. stock higher in 2025Free Capital Efficiency Planning - Jammu Links News
How sentiment analysis helps forecast Palisade Bio Inc.Buy and Hold Position Summary Review - Newser
What is the risk reward ratio of investing in Palisade Bio Inc. stockTop Growth Review With High Returns - Jammu Links News
Palisade Bio Inc Azioni (PALI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):